According to the four most relevant genes (based on COSMIC database) KRAS, TP53, CDKN2A and SMAD4, our in vitro tumor model covers the mutational status of 51/114 (44.4%) pancreas tumor biopsies. This evidence concerns the gene TP53 and pancreatic neoplasm.